-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 DgGaXYA9vyXZ9NHwGctkTSyKRDQK/DM6Kew6mZp2Jc92ILGihqgfKLBxSkWOhWsI
 R0h0LsUlJ50ppmTeb8aZZw==

<SEC-DOCUMENT>0000950153-06-002678.txt : 20061102
<SEC-HEADER>0000950153-06-002678.hdr.sgml : 20061102
<ACCEPTANCE-DATETIME>20061102161911
ACCESSION NUMBER:		0000950153-06-002678
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20061102
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20061102
DATE AS OF CHANGE:		20061102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORTHOLOGIC CORP
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21214
		FILM NUMBER:		061182964

	BUSINESS ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
		BUSINESS PHONE:		6024375520

	MAIL ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>p73097e8vk.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>






<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 0pt"><B>CURRENT
REPORT</B></div>

<DIV align="center" style="font-size: 12pt; margin-top: 6pt"><B>
Pursuant to Section&nbsp;13 or 15(d)<BR>
of the Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report: November&nbsp;2, 2006<BR>
(Date of earliest event reported)</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B><FONT style="border-bottom: 1px solid #000000">ORTHOLOGIC CORP.</FONT></B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="31%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">000-21214
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">86-0585310</TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top" nowrap>1275 West Washington Street, Tempe, Arizona
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">85281</TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code:<BR>
(602)&nbsp;286-5520</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR
230.425)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR
240.14a-12)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>

<DIV style="font-family: 'Times New Roman',Times,serif">












<!-- TOC -->
<A name="toc"><DIV align="CENTER" style="page-break-before:always"><U><B>TABLE OF CONTENTS</B></U></DIV></A>

<P><CENTER>
<TABLE border="0" width="90%" cellpadding="0" cellspacing="0">
<TR>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="3%"></TD>
	<TD width="76%"></TD>
</TR>
<TR><TD colspan="9"><A HREF="#000">Item&nbsp;2.02 Results of Operations and Financial Condition</A></TD></TR>
<TR><TD colspan="9"><A HREF="#001">Item&nbsp;9.01 Financial Statements and Exhibits</A></TD></TR>
<TR><TD colspan="9"><A HREF="#002">SIGNATURES</A></TD></TR>
<TR><TD colspan="9"><A HREF="#003">Exhibit&nbsp;Index</A></TD></TR>
<TR><TD colspan="9"><A HREF="p73097exv99w1.htm">Exhibit 99.1</A></TD></TR>
</TABLE>
</CENTER>
<!-- /TOC -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>







<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Section&nbsp;2 &#150; Financial Information</B>
</DIV>

<!-- link1 "Item&nbsp;2.02 Results of Operations and Financial Condition" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2.02 Results of Operations and Financial Condition</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On November&nbsp;2, 2006, OrthoLogic Corp. announced by press release its financial results for the
three months ended September&nbsp;30, 2006. A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated by reference herein.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Section&nbsp;9 &#150; Financial Statements and Exhibits</B>
</DIV>

<!-- link1 "Item&nbsp;9.01 Financial Statements and Exhibits " -->
<DIV align="left"><A NAME="001"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits</TD>
</TR>

</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="11%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<TR><TD>&nbsp;</TD></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated November&nbsp;2, 2006</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "SIGNATURES" -->
<DIV align="left"><A NAME="002"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dated: November 2, 2006&nbsp;</TD>
    <TD colspan="3" align="left">ORTHOLOGIC CORP.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ John M. Holliman, III
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">John M. Holliman, III&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Executive Chairman&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#toc">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>
<!-- link1 "Exhibit&nbsp;Index" -->
<DIV align="left"><A NAME="003"></A></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Exhibit&nbsp;Index</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Exhibits</TD>
</TR>

</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="11%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<TR><TD>&nbsp;</TD></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press release dated November&nbsp;2, 2006</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>p73097exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Exhibit&nbsp;99.1</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%"></TD>
    <TD width="5%"></TD>
    <TD width="47%"></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD align="left" valign="top"><IMG src="p73097p7309700.gif" alt="(ORTHOLOGIC LOGO)"><br><BR>
FOR FURTHER INFORMATION:
</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top"><FONT style="font-variant: SMALL-CAPS"><B>1275 W. Washington St.</B></FONT><br>
<FONT style="font-variant: SMALL-CAPS"><B>Tempe, AZ 85281</B></FONT><br>
<FONT style="font-variant: SMALL-CAPS"><B>(602)&nbsp;286-5520</B></FONT><br>
<U>www.orthologic.com</U><br>
<B>N</B><FONT style="font-variant: SMALL-CAPS"><B>asdaq</B></FONT><B>: OLGC</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 6%; margin-top: 6pt"><B>Melanie Friedman (investors)<BR>
Stern Investor Relations, Inc.<BR>
(212)&nbsp;362-1200<BR>
melanie@sternir.com</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ORTHOLOGIC ANNOUNCES THIRD QUARTER 2006 FINANCIAL RESULTS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>TEMPE, AZ &#151; November&nbsp;2, 2006 &#151; OrthoLogic Corp. (NASDAQ: OLGC</B>) today announced financial results
for the third quarter of 2006.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">OrthoLogic reported a net loss of $5.8&nbsp;million, or $0.14 per share, for the third quarter of 2006,
compared to a net loss of $7.6&nbsp;million or $0.20 per share, for the third quarter of 2005. For the
nine months ending September&nbsp;30, 2006, net loss was $28.8&nbsp;million, or $0.71 per share versus a net
loss of $19.7&nbsp;million or $0.52 per share for the nine months ended September&nbsp;30, 2005. The results
for the three months ended September&nbsp;30, 2006 include stock based compensation expense of $0.6
million and recognition of a Chrysalin Product Platform patent impairment loss of $2.1&nbsp;million.
The results for the nine months ended September&nbsp;30, 2006 include stock based compensation expense
of $2.2&nbsp;million, recognition of a Chrysalin Product Platform patent impairment loss of $2.1
million, $8.4&nbsp;million of in-process research and development costs related to the acquisition of the
AZX100 technology platform and recognition of income tax expense related to the recording of a
valuation allowance of $1.1&nbsp;million for a deferred tax asset related to an Alternative Minimum Tax
credit carryover. When these factors are considered, the three- and nine-month periods ended
September&nbsp;30, 2006 would both show a decline in expenditure levels compared to similar periods in
2005, related primarily to the reduction in clinical activity and
infrastructure expenses between 2006 and 2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company had $74.1&nbsp;million in cash and investments as of September&nbsp;30, 2006.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">OrthoLogic originally issued guidance for 2006 for $35.0&nbsp;million in cash burn. With careful
adjustments to resource allocation and the interruption of the fracture repair clinical development
program, the Company now forecasts a cash burn for 2006 of $15.0&nbsp;million.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;The OrthoLogic management team continues to operate with an intense focus on value creation,&#148;
stated Jock Holliman, Executive Chairman of OrthoLogic. &#147;We are
performing the essential preclinical and other development work on
AZX100 that will support an IND filing targeted for year-end 2007 in
one of several possible indications. We have no immediate plans to
re-enter clinical trials with TP508, but are continuing our
development efforts to define mechanism of action and address dose
and formulation issues in the fracture repair indication.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Conference Call Information</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Management will host a conference call and webcast on November&nbsp;2, 2006, at 4:30 PM EST (2:30 PM
MT). The call may be accessed at 800-599-9816 (domestic)&nbsp;or 617-847-8705 (international), with
access code 36319451.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">A replay will be available beginning November&nbsp;2, 2006, at 6:30 PM EST until November&nbsp;16, 2006, and
may be accessed at 888-286-8010 (domestic)&nbsp;or 617-801-6888 (international), with access code
54229516.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Additionally, the conference call will be webcast on the Investor Relations section of the
Company&#146;s website: <U>www.orthologic.com</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About OrthoLogic</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">OrthoLogic is a biotechnology company committed to developing a pipeline of novel therapeutic
peptides and other molecules aimed at helping patients with under-served medical conditions. The
Company is focused on the development and commercialization of two product platforms:
Chrysalin<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> (TP508) and AZX100.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Chrysalin, the Company&#146;s novel synthetic 23-amino acid peptide, is being studied in two lead
indications, both of which represent areas of significant unmet medical need &#151; fracture repair and
diabetic foot ulcer healing. Based on the Company&#146;s pioneering scientific research of the natural
healing cascade, OrthoLogic has become a leading company focused on bone and tissue repair. The
Company owns exclusive worldwide rights to Chrysalin.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">AZX100 is a novel synthetic pre-clinical 24-amino acid peptide, one of a new class of compounds in
the field of smooth muscle relaxation called Intracellular Actin Relaxing Molecules, or ICARMs&#153;.
AZX100 is currently being evaluated for commercially significant medical applications, such as the
treatment of vasospasm associated with subarachnoid hemorrhage, the prevention of keloid scarring
and the treatment of asthma. OrthoLogic has an exclusive worldwide license to AZX100.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">OrthoLogic&#146;s corporate headquarters are in Tempe, Arizona. For more information, please visit the
Company&#146;s website: <U>www.orthologic.com</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Statements in this press release or otherwise attributable to OrthoLogic regarding our
business that are not historical facts are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. These forward-looking statements, which include
the timing and acceptability of FDA filings and the efficacy and marketability of potential
products, involve risks and uncertainties that could cause actual results to differ materially from
predicted results. These risks include: delays in obtaining or inability to obtain FDA,
institutional review board or other regulatory approvals of pre-clinical or clinical testing;
unfavorable outcomes in our pre-clinical and clinical testing; the development by others of
competing technologies and therapeutics that may have greater efficacy or lower cost; delays in
obtaining or inability to obtain FDA or other necessary regulatory approval of our products; our
inability to successfully and cost effectively develop or outsource manufacturing and marketing of
any products we are able to bring to market; changes in FDA or other regulations that affect our
ability to obtain regulatory approval of our products, increase our manufacturing costs or limit
our ability to market our products; our possible need for additional capital in the future to fund
the continued development of our product candidates; and other factors discussed in our Form&nbsp;10-K
for the fiscal year ended December&nbsp;31, 2005, and other documents we file with the Securities and
Exchange Commission.</I>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">###
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Editors&#146; Note: This press release is also available under the Investors section of the Company&#146;s
Web site at: <U>www.orthologic.com</U>.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ORTHOLOGIC CORP.<BR>
(A Development Stage Company)<BR>
CONDENSED BALANCE SHEETS<BR>
<I>(in thousands, except per share data)</I><BR>
(Unaudited)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">September 30,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">December 31,</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2006</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2005</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ASSETS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">36,890</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">35,111</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Short-term investments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27,318</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46,437</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Prepaids and other current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">480</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">857</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Total current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">64,688</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">82,405</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Furniture and equipment, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">403</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">525</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Long-term investments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,930</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,084</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deferred income taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,106</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Patents, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,223</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Total assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">75,021</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">88,343</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LIABILITIES AND STOCKHOLDERS&#146; EQUITY</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accounts payable</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">852</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,036</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accrued compensation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">642</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">711</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accrued clinical</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">472</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">544</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Accrued severance and restructuring costs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">178</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">602</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Other accrued liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">813</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,089</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:75px; text-indent:-15px">Total current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2,957</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,982</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Deferred rent and other non-current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">372</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">183</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:75px; text-indent:-15px">Total liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3,329</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,165</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stockholders&#146; Equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Common Stock $.0005 par value;
100,000,000 shares authorized; 41,564,291 and
38,124,742 shares issued and outstanding at
2006 and 2005, respectively</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Additional paid-in capital</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">187,708</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">171,355</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accumulated deficit</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(116,037</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(87,196</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total stockholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">71,692</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">84,178</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total liabilities and stockholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">75,021</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">88,343</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="7" align="left" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ORTHOLOGIC CORP.<BR>
(A Development Stage Company)<BR>
CONDENSED STATEMENTS OF OPERATIONS<BR>
<I>(in thousands, except per share data)</I><BR>
(Unaudited)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">As a Development</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 0px solid #000000">Three months ended September 30,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="7" style="border-bottom: 0px solid #000000">Nine months ended September 30,</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Stage Company</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2006</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2005</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2006</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">2005</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">8/5/2004 - 9/30/2006</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">OPERATING EXPENSES</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">General and administrative</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,414</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">1,027</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">5,567</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">3,210</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">12,355</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,651</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,266</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16,575</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18,660</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50,099</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Other divestiture and related gains</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(250</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(375</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Purchased in-process research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,471</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34,311</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Total operating expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,067</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8,293</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30,613</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21,620</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">96,390</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest and other income, net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,250</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(700</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,879</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(1,906</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(6,270</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Loss from continuing operations before taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,817</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,593</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27,734</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19,714</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90,120</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Income tax expense (benefit)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,106</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(12</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">356</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:60px; text-indent:-15px">Loss from continuing operations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,817</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7,593</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28,840</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19,702</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">90,476</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Discontinued operations &#151; net gain on
the sale
of the bone device business, net
of taxes ($267)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right">&nbsp;</TD>
    <TD align="right">(2,202</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" nowrap align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">NET LOSS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">5,817</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">7,593</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">28,840</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">19,702</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">88,274</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="19" align="left" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Per Share Information:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Net loss, basic and diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.14</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.20</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.71</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">$</TD>
    <TD align="right">0.52</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="15" align="left" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Basic and diluted shares outstanding</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41,545</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38,025</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40,496</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38,019</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="15" align="left" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>p73097p7309700.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 p73097p7309700.gif
M1TE&.#EA:P%"`.8``/W]^CB;IEBKMIG*TNKS]O+U]*K2V?7Y^=/H[!V;J_7X
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MYBV)D/[]_3.0H$^KN=OM]<CBX2Z1DYS,VU>;HO_^_O[^_O___R'Y!```````
M+`````!K`4(```?_@%)^?G^#?AL;A'^+C(V.CY"1?WTA(8:5@T>*D(B=?9.&
M?D=,&1F)=7V?DJNLK:ZOL+&RD:)2J:(0FK=^3$R=&ZJSPL/$Q8^W1X)U=8A,
M4G6\3(3+?GU2HZ2"QJ]]'B')?M1'$)N.OYV&4NH0$*6:J,';\O/TQ*+AT-?/
MJ'\;I$P`.M4;2-#8AB/O1K$[XHT9*@_@UD%`(BV4Q8L8,V9,A:W3E`SE&O$Z
M1PH).3_J4J(,6;"ERWF\!`WJY>N0/YJE,FAZR;-GHPT!^_B!@`,'N8:4^AB%
MH&VHT7-0HTJ=^BM5KX!`B0!@N:C6II+D)J4JA%*;S[-H60T%-VY$+BDT_YU=
M0V@VK=UMU0"L60.@DCI@R^#]\0#M4*$C.'2E6LRXL>/'D/O4J51'V61ODBPN
MZB1E$>-"ZKC>'?U2LH?3WBJ%8-:+G<Q*I&,+2T5DC=80'F9X`!9ZT!\E'G@A
MG*!DQA`(0Y(K7\Z\N?/GR4<@08+CP`(<2X94D;0KE(<)$V:$R^T!P@B$"'.)
MELV>6)\9X$LH`3_AM!<EHY!H"J$[7OO_C\Q01P9+-/!&`PN\\((2JS%QTA_L
M.'C$?%HLT``!&&:HX88<=NAAAV^$V,`+!ZRW&"Y*R*>$$D,8=]QEU!P&X(S%
M5%'%$AD`X,$4'WG!`0<S0'``.*O1:"0C=4#P@O\,1D`!!!1B)(%&"1/4,8-D
M?^!PW@:YH5&#!0R<(>:89)9IYIEHDLG`F@R<($09%FP!`2V(@.+!$%KB\`(:
M%B*(0P9.>)'<3$<6^LH,`"RA0`:ZU>'@<1Z,,,(U`"5B*(!^5)B$"D_P(800
M;5@`QP@K*M%-'9KX`<`$0[RA`ALB."#KK+36:NNMN-+:11<WR!K!#G;X@$,D
M3&!`!#`3<(!&`QH@,(<)`Z@PP``&_"#!"[F<MMZEAOI!P)X+'("&I'HBB,:X
MAV2``4C<MN?'`F\`P8<*8AAAQ!YQ?*#!#"5<&8)0HVQ01PE:)''!!08DK/#"
M##?L\,,.0VN"`13(L-/_(P!@@`&7$^"@`04DQ!!`%VFD`0,,*X"`A0I7O(`#
M$B)M\IEGD'PR%B-"L63(*KYUY=MBCH3BGUAD!;VS2#X;+9H?(URA`A#2&D"%
M`=$"\<$5:&C!#`!@3+%TSZKXMO.)/1]#2TB:8:06(4/'_/,GH3`B10,&\$$M
M%'+(D005<5#Q0GEA2>'6!OSAL,`"6>.@A19%*:[%"P@>+GD#D4MN^>686T[`
M&R\LCH,4GHP%```],/I%`0CP('+*,0@@0`PI!)"&`P\(P`,<+WC1`Q&Y[50'
M:JB$8TG.DTPFO"6#+',$V>D,(M4XB:"$T'BKC862:]080DD(!PDRU@9PI5K]
M_TJB*/:)%!E45$TJB`"`0QAQ/&''`P\487\`*PA!0=:\8"6)>?OY5UD&$1K*
M",Y[1;L,(A31/B(<JP^<44?`_&$>]4`0$8T!BD[\@+QSI&(NR=B>4*Y1#50<
M009E``("&""$,8RA#$D@@1!DD`7S>$`H[!C/`9!0!^"@YH<>4%?Z4`.!*6``
M##E)HA*7J*XIS"!(2,!`H(;4OEMLP(%>\$`5%B`&%*P@`&?X0`Z,`(<DP$$,
M/,#"`V`0A``PP`@+:$$+@O2+WQ&F&="0S&HR@1!,E!!5JE%-8`J#D2/H)#V2
M0HBV"-$,)HS`%^!##UP`("%P&$)@@4F53+2WF-$%!/]T&&P?$F1`!3-T`08)
M8($;6-`%+!A``\GR0RF`(8EQ6":2Y,@'/J"1R_--(S?@NZ0_2L&^7J3D",Q`
MQ$*\AXX3.2@7DX$&*1H(@.EH:7G+&*$ENY$$(5R``#%0@1'J]H,+T*`#64"(
M;H(CA8`X85%(.(`\YTE/!=AS"2,8PHK``P:-^?.?``5H`0J0G1D@00$#;8(Z
M/)F>)0"@#@K0@`EB(`(!&``/(\(.0B\D@;KUR@HQF$,#9E"4)3@0?()HWRR[
M(2!$9``)DUK?+9X!Q#O>)"XT\60I6L,.=BRC?0);32ER@9[1,:$2=)'I-R3H
MO8M`A100B$LGD+``/`P@`!'_2(`;=*"&)+R@!!P(R$HS(\D%DA`:T[M@4.M`
MEFI4(GH$3,D^+FB(R:CF-*L)GDH6,9=G8.((T_$%`#+PD86L3WOA,`0$ML`'
M";SA!'N0P19.<($K\.$"6MC*#)"9S`U@8`0$Z$`29$#:TI96`JA%+6DUH($W
MR""UL(VM;"60A"1(0`8:P$-MD]"`0S`!1TQ`2/I:94X[""`';T!#`3C@!#(X
MEPPM*$`#*("%"`3!!G?(P;CT9`JQ!(9[G1C=+YYIBUULH!2>3"\1P,#>]K;7
M@9Y$1SB>.`/D^6$")?!`+P:Q&$2$H#[9'-\X4K6^[*GD*SMM!U,FL0$M$``!
M,8B`_QLB4($+%*`$)=B=4;=%E)CRHQ_:W,E8*).T[EC$KA\&Q3($@9O3!(9]
M=>K'*3`AA8D@H4[\'63P$L%2PD@!!V*(@P8D<`8SY$`%?+B"!(1@@`5L+!G8
ME,P0T,"W%%3@REC.LI6SS.4N>]G+*0AS!<(<@QJ0@Q13V*0'M)"#%-A!5!<V
MW!,!4!N-*>``!/@!"FS`@C3$(`<O*`!,EX>2>"HH,7:%ZVJBMXL/]L8SD6$?
M6@F!$BO-P!<<*<H1&@6/:[`C)X&M1B:>`1_QC`,?>JPO96R2B!I#LPY+J()T
M/W`#&S@`"PAP@@.-)9!5D,+2WX@J(K*93<9`PV<7$0LE3O\#"N>-SH$6)-]D
MK+&?P@@L$QTF!\"J`92@7,80W]DL&@Q0AC<L&00@F%<4-""$`3AY`[F`@&2$
M,H-Q\R%V`<BWOO>-[@"@^]_T"[C`!T[P@*<`!!5X0+HI`(%ACNZ)'9,`%M)P
MAA\@H0?U&4&CNNV/.Q%`#%SH0A!N<`(--&$)B!XL0@N@`)<AP495D*>6P",>
M)E2!*3:2N5M@FD_I3$>>2PAZT"F)A%ACP)Y*X(`"P$"$'DQ!41`@S[_Z<(0A
M:$&?7O`"&(*N`*:-P"C`&\((P*.$"IU+<06H@GS@0_,:OP,),Y@"#DP0`18D
MP`(:R-$L,<B*3;?(/&[)I]G1<`#_@F8`##T04/;2H0U$]`#C9>=`S,]U@"GT
MP+D]6)47!FL2*RGJ!4B03SP)>Q"B4&<)3,C-I0EDSP,LC@-@U=)YH#$"*HSA
M#>PF@0J$((8"+-D$#6C!!LX3#@@"0`DCZ"@5<L#\YC>?"C[P`16FGX/I+]_Y
MV,^^]IGO`ZE=0`.:J%1XYJ,!'MS@!@8@0.:/"A[[#J+%!9#H`R(0`?03X.8,
M08)T*7=0!4@*#1I``.$">_,!40J0'=+Q`@F"!M0A>X9&(@>@(`IB3TU``,'7
M`DW0!&@0:`4`@?($`?45/'Z``VA0%&CP(_%$.41A'O)D$G[@`1@V`F]P1MUW
M`5O`6P6@_P40L$\34#[5`()$``$&``-V9P9OD`R6`0]MLPA/-`KI\W4X\`9;
MD`,)0P$_@``:H`!5D`&N,05'X#.-!P#O9!T$L&ZZ548R\`).\`4^X@43\!$*
M@`-,@R$O,`1@12+741+Q=`!,,0(\\@*N949)@`>XI8!#4![3`P%&0`-P(`%E
M8`(=,`8#\&!\0`%.YD@,<0A8`6_R-`4.](F?:$\*@`&/5SI(@"URE8JJ*%>*
M=!HC$"Y+P`'6(&R01V5%D`8HH`$<0`22\AV$(32_LP0%<``28`$W$`$.$`,=
M,`*Y\8I7``4FD`,4(`87,'T^P`,?H`(7D`0:L`!:4`5%9W5H@/\`TV("TB<&
M-?`#ZB@&%,!\%%`#\%@#%$`%T`(%6`@%)#``/M".4P,%!B`!.W@EHA"%%P`%
MRV>%-5"0<O`&8Q=$2X`$W\$!6H`'5.`"*7`#(B`"*T`#,?`!%"`!#3`E\H$+
M`/`'FQ:$0\@"+&"$V"1($+2$@W$:-D)526`"#'"1&>EO`O`!8@"2#5``%D0V
MG=`$S-(!.6`!)T`#3_`$-"`$%F``6]``0_`CB&(22D".YD@!1B`&<^`#)I`$
M[<"%Z6$A;V`P,D0#=L"4?/"(4:D%57($Y_4&=B,#8P`%&@`%0@`'=2,!68`!
MN?`'J)(,=9!>6N=>[K4&S^5<3H!GK?7_(8[Y!AJ2(.%Q):X&%%N$`!8``P&0
M`UG``2'@@L`02=MT`/9$`!1P!S<0!"+P`4<8*00`!6R@!SI`/QA),B9S`P&0
M`B3P`Z#'<E6@!6\P`##@`$%0G#I@/_93/UUPG,A9!#JP`PX``T]@`$E0!FU@
M!_-3`<^I!W&P/U$',.,X!FUP?@$G`FPP!C)`*A,P.BFB!`10`R?`!BN0`@)P
M!E@0`R"P`FT``BA@!#*``_AU7B;%)1X```>0D@E@A(!A"7\18YS`+_W2`!<`
M*BO0.F$B,E;0!BE@!AV0(#@P!*LQ/K_0`!+@`PSP!"!P`F:@`BI0!@*@GR"@
M`ENP(%2"$ED@_P<@@(S'69P[D`(Y`$D",V6`F`,NP`8T@`46P`,J8`%"H)20
MA0<-N0%+\`)F<`=B``1AH`$Q1`%E4`8-4`+X5!,Y-`-*@`0EV("-DZ9"%W2`
M*`9@@@)P&J=R.J=S>@9RZ@(UL`!3B0N^0`1+H`$&``([0`)O4`!?-QGPUFJ2
M-!-#@`%,\`86H`,)X`!66@`9$`(C0$IG,#M!H`,H,``FH`(N4`$P@)M88(D(
MU9D:\`&E2C]==C(PH`->5G]/L`<$(`%'F09:I9EFL`4+``'9X58>L`!&,``I
M$"O160$#L`4X4!Q'MRH30``J0`,K8`$YP(TA(@,UH`(5<'YVHP$X$/\<!.)`
MN`$&!TJ$-F`&!&`*!_%U%+%`;O,'2]`"GP4')$`#-/`!<Y`$%>A::%0!)B,$
M<J`!E7<9[`1*)S0`3[`"*-"3"6*!24`!%I"?,>`#;[``XE%$&G`!)Q``Z!H`
M*)`#&H!!E*`$+R`!`T"M##`'$D``\D2B%'`"*[`"+K`%!U!?`*`%6R``+I`'
M4;``,H`'0!`'8C!2U&$*WY`,4W!G$D`!3ONT4!NUU6<`#&`'(E><6)NU6JNU
M;N`&02`K.X`%5/`#"R`]A^`%)WL"-[`#/U``2D!4#0=7&'$:&7``-9`"Q5D$
M/"`#4C0%\$(%,9``"8`%-0"9!"`#<\``Q]C_!2>```<0'EH@`Q9046-K!!W0
M`5L`!QTP?S"``A1PN:!;`P,0`T^@`@UP`!^#!3;@!EW@`E)R'L$E:B$P!$LR
M`!7@``EP`R8`I;E1!V"@`%,P!!HPK4PF`0LP`@`P!2:A!1I0D2L``P^P!Q*@
M`#H"`0JP!JC"A51`A`G:`,`@/6GE#]HS25+:!`60!&J0HA<@`][(A>QPL@8@
M`!&@`WQ@`+E#&)7P4@<U!03``Q60KU)"#I5`4@N``!<@J!6@!A^``!.`4$C0
M`#7``*B4!A;0H7+8!Q!`.AP@`3R0`C0`!'"07.N4&PW0`20@J%RP!]^'80M@
M`'%0!M2RI$)@ER/P_SM/<0254*!_.JT@L&\^_,,K(`(PX`:3FBNY(KBSH@,W
M``)Q@`"ID@H<L`!;,'\/@`=9\!%#\:Z20%-!IP$6<%U!<`8R<+U3\'4K1,0,
MP+<*D`43L``QNP-N8`<J@`:$D7P,L`+N-@2HQU]H<`<)``,DT`#)``R_10`F
M0`,DX(W,H@)#'+U,T7#D0VI,H`!7@`6XFP(=\#>5T`=^B@0$$*@Q`'PILAMT
MM@%E]P87X`)\5@'V*RC`V@-;XP$Y4'=N8`9E&PFC@&JD,#I3<`!OP`,/<*K7
M026EYP<<L"0^<+LP@&M5(!Z#$$\CH``-0`4/D`8\D`03$`_./`0$8+L.0/]A
M%#`$"$44;_`!76`#,`!\#"$($$`$3E``5"`[%H``(Q)U@=0Q</`!`6`#M5,#
M6L`B&QL'^-J4/B`#0Y`)C,`0]2$D;V`"0B``=Q#1$CW1%*V=$N8&1HPK@KO1
MLJ(#*<``$O#$?5`%#>`#.@`#)]``'(`!2X`+R[/%./P1+V#2:=`%*\!;1.`%
M1S`"J[I**"`#2PL`)?`"H84%)P,"28`#09($:R(!_^P%;?4"=Q`$$?`!@@PZ
ME%`%:``'8T`"!.`!!X`#%*`#-E`!.3`ID#P7#0=K"B`#:B"X6"`!!^`!@,D]
M4]``.<`';/!*(Y!?J$!)7%(":#"#9T`R`@`'1&'_%!/`/3HRRZIDRTL##%;4
M"27@Q@&`!6*@IR60"R-T"!C0!*1TK'K@NDA0%M5$,!00`S!P!GBP@>40'(MP
M!("Z`CH0`"8P`SV``1,P`@U@`F2M`SF@ISZ8*#6`!72``G"0("9Q)8LQ`U$L
M`2YPT@]@``?``4IP``V0!%=P!0@@`PTP`I1&UY[1A(:#`P106PB0WNJMWIJ;
MN7!@!#\PN0Y@`_1=W_9]W_A-WR?3!180)06P`9`V2JRJ`Q_P54[0TN4#D]?0
M;3A@!'=@`T&0!E2@?D-0==V<2C^M!"R'<4)B`G:@`R)`!0LP`4R``&/09%G0
M+X")*@UP!]_\`00PR-U0_P)12`)`\`:X\`-%D`!WL#\C@0L3@4SV]`9F,*EI
M7"+",R`=X`)T0`(:L`0]X`&),4(;4`6Y42%S$`#/^0%H("2DPMBR3,N0'0DD
MJU9VQ=1L8`(+4!PE8!*WT`=.L`8(Y2KSAWX-\$D;,`19(+DB\`!4<((E$@E]
ML.<?(`(!P`-38!MB]\GGK`.9K03E@QL-0`(B4`$^0")&439#H019H`1&P`4V
M4`0#4`"P?'070@`Y""1=P02,D$L_I@!$L+1I.NLEU2(K0HQR8`*ZONN\WNN^
MWNO7^I-D(-FI\`(_,'%F/5(MT-)[I."=@0@X4(PZ(')&""03TMNXF^$O`.O?
M<?^5U04#*D``0Y`!27![^E0"6Z$\!.#B$1#N,N[<47P%8?"A3#`#1O``"5`!
M8M!P`6&2DH($SS`Z"\`#"6`#%J#2J/*",[``*A``,;`%6M`#B9`8H;`$\Y$B
M!&`&LF('<$18/]788G[+9`YCA$,8JVH'+B`#5#("7C`#WH,*&-`":X`!S(L%
MQR@`'<"NIHP&)B`[*O`&6N#:C0#;?L`O+P`',;`")+`$9$`$!\#-5)`&;O``
M>=J$#.$!!G"L:J`!P,&,4=451R",&%;2QSD`%@_6!?`R$)`L'"#>X<`(I8T2
MI(EX5;`4/77WX($&,I#><(``6P"Z@!_X@@^ZEGNY/]#_`7TO`2WP4/#0PBN`
M70@P!)X%$M4#D_R%"![0V]/N``(@`4I0!6.W`":0[3(P`4B0(\LP`V_PU@G@
MU4$D`W)P'N/P:D>P[M]LNC+^.T&R)P%3!YN;[V(`ET'1%I]C?`,/X2[0`,4!
MD6T.84K_!@*B"0=!8`RQ&E)N!!=I!20@`TM0QK'LV+4L\L<@V5)`BFZX`#EP
M!R)``07@!5_7$`%T102*`X&:`")@NIN7`27P!@(`"%T@$A!(."-^?XI_?HE^
M1P<*#1\!%@5D8$@3:!0!;ETU+R5'!3,<#0PB.W-H7B%'C["-4DL*(Q-*$EQV
M/#@S$!!#$$=21QXAB8S)?T<A_Z\X!;8X:#C5UM8+#1T60@+>7.#AXN)86.'F
MXP)<6"<J&DQU(7\;#0-I"5PR?GT9&?MU??HL&J@H8)\-&V:@J7$C`8L*""9H
M@3!C@0D'"5#(^`5A@Q\I=1;P"!*$!($C`)8L.`)AA,L1((\0N.,@@HH&Q#;T
M^1@O1!V`.CL$2%"!PA&$`':RQ"%E'@"1-H*X:#!D"!(('!;LV9$B1P$/1Q`!
MV`!+T<<-```0D>'B!HP8-9`X67(0@(<<$5BX,;-@&4&$`:40Z:%DQ!L+-U+(
MR.($"<LC+/TX`_C16!(4$2*<0*!DPI01<`(X0($&`!,(?@E*.8"!R04^91I,
M`3-C`O^.3FY@U#A0Y0@&+P4ZI(@00T*!'C[--DJ4%D*="0L&@/B`(X24Y8D"
M>B2HZ,B,&1X@H&E@Q(2)/0/0#UB/WL0`%P$BU(P``X:-^_CSZ]^//T&""%:`
MT`$$'G@PSQMFP,`"%P3XL<$PC03$W4#Q(+1!%0?($(`-+`1@A!8SL&011BYH
M,`,23'ATE!8#!*&#21`LD4$(&U0S`DL@U=$`33;A)(5.D/41PC%U`6#$4$4=
ME=8&C!R!1%-H0255`Q.40!$:,G"Q0QDR*`!`9&/IA!T31)190`XIW"#"!PNT
M0!=:=^6U5U\3_L$$$X%-T8(7"VP!@@@6+)`%!AGT`<%UQ$C_%H)2SJ%A@!U!
M!.`#!%Z,L(`!:10Q``YU>)`:07Z\@$06,@!1QAL03#'!#$/@IML!2PPQA1,$
M#"#"#29%L4%RRS%2QUC7?0?'&$"\L,\B!UG()'<0#.D!``=H\`$;\65FK;4B
MB!"!#CKXEX`#&'DK[KCD?AMN`FXD<$,`/Q!HX`9OH!`$"R@T<.A/4EQ7YR(A
MS(!0!DM4T4`,'*[@E3!(U(J1!1IX<$!'%E:QAP-%W.0!$QFDA8-C=2@9$H\W
MY;23(W5E#,`/2%*0XI)^U.''H0X^Q8,-;KA`P!`EK/J"&$5TX4X!2/STB%H;
M%+./@QN4P($,#-#'0!('3%$'G'CI_\77IXI@W(?+`#A!!`$FB/#`!3@HD(%'
M0C>2Z,A2X()`"@GH$.BJ$KA@0P5Q=5K'OG_TL2H'+UP@1P,X+#&%!ZUZHIL"
M2T3MA`PHP/"``044T*PCUPD)GC-]`#`#`5!`T8`4`C5B8:_<#3GU%`J\4`,)
M9K@@^^RS6X`"35&5J_ONY$:PKA'-RK.!!@($X88:"SBV4[Z`[1O"!/]FD$4#
M9W!HAP%-5($$$F\,L+`&$+S0T5@`5#&`Y%`LX,$42XQUE3$QA\1%33<Q;Y#I
M`&2`1%I'$D6!!U,#0$]>=ATFR(QF-AN"$GZAE2[8X0($:(("ZC"#.D"`:`_Z
M!T)*\(4%J/\`(W<0PP$X0".[5&U.6+-3H5RV@1YX00(6@$$%DL"Z)11M!LY`
M!C!(9Q!6:<`%"HI!P[1P!1!T00@2`,`C&K&O/I0`!R7(@@8T0`U8(:X3"5B<
M`I!`!"=T``1$"8,"IL`!@#"B*7WP``X+A!;;2*`#]E)&OJZ#.H(("2`I,00:
M7L#'/OKQ#3*8`Q9`\(``&/*0B$RD(A/Y@$86$@0ND,$PB`&:&!A/#3A`2('Z
MMC6!U,D@&V#"%&9P`!+`P`TW,,$(E."!A%TD`@R0`1(:L+\9I(4`%M"!%?"`
M!D/AP!'[\*0B7C"_"+`I6=PYW1]^\(`(I(`"'%C@#)2P0"8<P`/_''`B&E00
M%09H``D7*H$&N!"$&'3@!1O3R4&2P<1%^`$'$&A`#892A#V,X"=4D]/5ZA09
MGLR@`$:H``R\.84"_$@R[:SC'Q#W`A-$P`8[@$,5+'(#*Y@!?+*@8SL'\IB/
M7*<8D+G-4&`@AA<H`%8<>!0,L"`##"@!`I]DA$!*5PQ]*2>%R%H>2S"VA%HH
MX*>,D]$2.*"2#M2@!F)(ZE&7^H,?+/6I4*W!#SI@!"/\@`))-8($L@`9)DAA
M!!VPY/$RB9:]!<2,33R(%+ZC!1+LX#^J9&4\+Y*`6$)@`3B8P`3NV@$LB(`!
M..D#CO9%S)H<$R%\^X,1BN"`%-2@?3X=_P(`P+`$)@QA`PI8P`=@$`1O.J8*
M$)!!!1)@3BU$1CLI?&?9WN8&'?0"@/FT&ITF!!F//D\+8GA`1MY04#S]X14X
M]<,2;M,%&\"``IG]@`A6\`$-W,@C&O5+(HR!#`DI)2RNVLU)EZ"%/:3!`=YT
MPEX32][R]BT61YB`%_(7*[U.H`KP'4(59$`!`YC`OO?U@7[WR]_^^K>_YO$!
M%;90QB-XM9)!R,@+EK0L\H)2"FIL:T,B``4<R+4!%P'O&RIBX9QA.`".?4$S
MD%&6"176F`M`)M\6:X.NO$!_/1U";:;@!0ZH5[.<+=$(F(`!),"A"PG`0A*4
M8#34ULD/-U*`#/^P$+=`53"V**Q3OBKSG0-0(0!!4`,!B*``WP*WB57`01)2
MX(`;#*``+["`*@9`@&%`MY/*J>D&IJ:LHD%F!-F-A(P68`8;9*0!3@B1>0=]
MY&)L`)M*6(`,)""#1CO:T0.H@"&+0.E*6_K2F+[T`S#]`!1(H*L/0D`,TG4&
M]7D`L1])40JW-K6C..P#$][4!,(SHKJ^@<M+P$4#\G`"-K@#"9*I8(FY<^+#
M-KA./]"!#1XP@`XD`0^+EH"TIRUM.%C`!@YPP1M&X('&_2`-,/`T*V&Q$R:L
MNC`'>(,+P(4%#4P@@'&2;0JG+`6*.,P$D#(#`=CGY6%SQP,ET((&[@#_@QM8
M@``O2(4(3&"OHS2B)Z5C"3#ZD98PH84)'L"SXK0K(P*<X5MJ*$`+P$+HDE/H
M1QO0-15LQX"6MQP%+3]!!<!%$G2YX>8XS[G.=WYS</G'`=UR0``H,(P4'4'4
M"1;`&]2(ZB-DP-R?Q.>A`/`"%33D!A4>`JT=FH`S)&$)0#L``2@@!!JX(`D$
M`*#>-DJ08J<8L7Q+MAN"4`%PG.'NX"B'WD]PA@JP(-O;]D!F<P!N-<B@!)XZ
M+]0GY$0M%`"7-8F!#)0`[Q/N<T+Y8H2]M_D$'>B[Q_W&:15JO(`S[.`&L5S`
M"6"0!H:++(U$8M0(<-``O&YO!/<:DL9SP_$,_V@@!20Q0P&R0'*3F]Q3!@1`
M`?#P@3;L(`W0A_X.Z@,#:\V'=]CW5F:^Y;LR&PPFJI:!`!Q`]PZ,8`9.`,/6
M"N&/(TN="4MXP0=TD(;)'<""&<!P7HI@`178UPP"D`8I,``2L``!AQJ*(DQM
M5TS&EE@_<`-!`"[1-X%ID"TWH"9=0!)200#<IA)44!]J(`$E(&CEAE,A@@,+
M\('$(0$84'GZ-%O<P43U]AT+8$H)H`8-D`7Z(Q!?5B=+0$TOX`(1$`0G0``:
M8$D!P'#VTP>;$Q`C<``OT`1```0\8`#X!0174``<D'%Y9C9+0`!P$P3"UP(6
MA%/&5R=U4&_ZLP`$4/\#*I`>>Q"'<K@'*A"`,.`?U1<!V<<[F7$?F0%N*2`&
MAY(B?:`!9^``;O``5*`%'-`#8-`IA;!XW/$34P,!\/<").`617%_\(=A%&,#
M`;`".V`'=H"(9U`#!>`%)3`$D-$,,Z"``^%V*K8OR59P#/`!Z<$><TB'<7@'
M<Z=M6N>!]($"0P861R.)W+%7./`"%%!]Q=&"4'9Y,9@(]89[-:B'6M8"._A;
M_D80L:($00@#&C9P0=`%>[``4I`B/Y%#`M$;2/`%0``"I-@%.Z`'-'`!:#!K
MN_<J9I,!8)@`6=8F97B&A-8'(.4=)5`%"E``!]"0#KDQ.)`#*#"19Z!W6'#_
M!ES@#1JYD1S)D18I`&=P`@S@#NFHCF^@!B01`&R2!6#PB"&2(OL2#Y4(,`T@
MA`YP!S\@61F@`&!#?@&``KAH!G=@/#:A`8@W#/4&$K"X"+((=[2H6Q5P`0T`
MA2^P`"]P`#AP``I4E1K09U+Q!D,0`L(89'`0(N2V3OLR!8>`9]\E`#+@!"XH
M;T=&C<`03R2`$2CP!HQ3*-R(4^T5A"(``S8S<)\P`"\02G.V*&B5<99#`'.@
M!EW06BE@`).'>/NH71DP!?^8$02@C:A!D(,V,I*A!!S``4K3DBV)`1@P&X_S
M`V+05+!I!%0%F[19F[8Y555E51T`!UN0!"W0!W<R_V<$8`;<L@/:QAH8X`$3
M0`Q+N0@R^2!(L`0-4`9W*``2100["39#>`<Y(`%OH`$^<`?R@04=P$HXX`'U
MAA(IU)3'-B',Y`!%H0!>H)H84!7L0TT0H`6:-80,`)8A,`4IJ(<Q8`2LB!I&
M-B'"I95(0`%MJ0%P&8TP""IT"0R3@)=O@`%+``$\V(WN%"LS$(0WL`/Z1I@^
MDTEC,238P0QA$18-0`5%8%Q8@``-4`7ZV(69V0!P,U`:T`(/8X:@22$&\3SZ
M"$]U6:0'T`'NL1XJ\(;KT:1.^J10&J7F`04=<`"IYA$>I`-=T`5G@`='\%//
M,S7-:19"4P@\.0:<)0`2X/\%/5`+VAEN"*``8!`%&J`".^``#[`'J8*`!F9#
M=<*>#O@`+48!6K!7&*=7`(`$'J`$(9`5,Z-A6C<%+Y`#G.58+H$:+-2>'8H$
M0Z`%E!H$6/`&#WIHEA>A`R&#=5FA72<#/<4$?=.#,=A3=]46.\`##4"8-L`#
M:(`6N^(IO3(,B.,!`%4!-I`&)/`&T?`PEQD)&4`$..H`,'`"$M`"XK-JG(0Z
M;%=>SU`X7J`$#8`'<)`$XIH$"$"N20`';9$M!7<#Y,<M%_BN\!JO\<HM.G"!
M5J`#(B``20`SDZ5QXO@`'<`!59"A2#.F?U`(S?"E!?`&,4`?!M``F+4$,Z!_
M$5#_(CTP!4<@9C'@C!J`H3>R/.O)@&^GJ031/T6!&@>U#Q[A$T[7`(]:!@3`
M*D[``7"@`VZP`P^;`<;P;G>R+_DC$7N0`#9@$N*#%A#@`PJR%PVP:A:2+T?P
M`G*0!FY0`3EPE;"`0]N!ADZ``5H`1#<P!]^)!3"@`V>@`6,!&:^X+V(V6EU`
M`E'S=%RX<<P*``0@!((:`W#@!8V#-4("%L\BIV=[!"7G*0;62F]@`EAP!Q6P
MN(Q;`82D`T"G`QHXN91;N99+$G,7@:?D`"``/-<!`!AP=.,'5VC``2&"<B2K
M"`@;`CNI`$D0'P\@!KMZ4MYJ`C=0L1IPL2.@!03``Y"[_P(7,$*UE:VQ*+*S
M6"?]\TPH6S0J^ULO(YTOVV9#``83(`&"ZC,-\'3P\W0Q"0!>@`8\$#<#@`8'
M`!,```$&D+1FL+1U@A3,:TT7D($/8`(+<`#$D#;[L@$80`0+@!DK<`4$0`!M
M<9,(D!9,<`1H-2&N"S=M*V,9$[>\IV?.Z@+*]DSJ]9G<T;?&``"`*UB"2VA)
MT2FL(@,JP`>AN`(HG,*&=(<W1R[@\L(P',,R["TTQP()$``#@G*F\09WF1NQ
ME#-^<,#$NPAWTC)ZLC/:HJ]:('@/@V$-42(3,%Q*@`9&D"8W(`0RH`4Z]".$
M9;Q.B;PIL[R9PR0Z!+W=U&930/\$`/`&6)`&.G`"K-H21\`/KEHG(4`$7D``
M:@`#73$"PB`%YYN^5L.^M+4DEIBH/T!F7;"^5CJ\.+4!:[`6-)$"QE%U;O%,
M&X"=&%PG"YP`#3P##[RL"K"_"J`"W<)L(_`%>^-^+3-9`&`=-C5H`-$IRHD#
M$D`!%!`&NAP&N<S+%W`"04!]+VQ],ES,,"P?W!<!S[<#,7H4N_).+1H!;L"Y
MA`H].MLR^:L3D.P$W5-PZSN")S5+MIL1,L`ZOJ`%,F`!1:`#3^`#"\"HA]S%
MAC6RB96\1'<68^R\,>*RW;1M4[":#4`":1`$CO455^$'W&O'ZB5^,"``Y:D$
MQ!#(ZDO_R#$80$C0K#,`!S'P+0*`!UI0!Z>!P#B5`2X$!S.7ETYP``9PISJ@
M`B.0/V?#-YW\R:'<A4NP!@6PTDWV`E_@`<VY'$6B1C?BHZECD);(J<&@!2^Q
MNX90OQ=@`2<@!")Y`E1MD59]U5?-`'=7#F<`<Y23+,@P2Z_K(B+``^^</P@L
M#Y^DS6O0`Q*`&2E`!3A@8PSI2@VA$:R#!J:`!G-`K#J0EZOB=``@SRAVO!-B
MLO?\(_E<QOS<6<[5-4Y0`..L`VR6J!KJ54=V!$I0`F-6L3)@8Q&-OA.=0A2$
M%DAP`$$C`R<`+@&P!4O\(,.PRA-"TE4@!EIJUDZ@!6&P`B2!_P(+H!;MMR\S
M30(.;!>B?-,M0`$K`'1NR:@_K5$"E'%H\,&$Y@S'X`%>0`08@GM%6J0C,!Z+
ME@32)JX2@`?F?=[HG=[H+0'D"@?.)JYO\`5)81!CU`#$668ID`31T#AHL,E_
MH2I=<P`YT$@'EUY@`0$X4"O=XG48`#2J8]\VJP-40``E`']@0-@-N&+=<K+X
MW+RO``'Y-S.[I053,`5?4@/`%P$"0``V5`=*D`%-@:`SR@$4L"XF,-<><)X]
M<+0*(H8431"-"@!#D.!7,`-18`0BX`!E3>'00R!J/2$04`4$`&LQ(`8*P`%,
M`$-=T%A)L&#@P3<'@`#$VL`>D#'8)?^W8T0$4_#6U1<`!J#7/RT+!E8%:""N
M!9"Z,3DD>E6:4+@`W-W=X@$'4%`&9<``LC.1,.=RB>YRC,[HB+[H*.`")E``
MF(/0B6H`S>0`.[`'!%")TY!":#$D)=``:J`#($`!QJ(W&4L`IMQU2=#@0?,3
M$0D"P4R,.KD$&$[/&NX_8NSA+!'B?M:?5:#F2W`$;]`T$>`A+X`!_5)91_8"
M65!U>B`$"(#=U;`^2"#(/D[:(8`5"Z$",O`%$A`#T*K$\%Q!?+,`",``5F`!
M7[?CM0*!$4"9$CL#8)X$;$O<9?XEHIP!A%(KX@@#9B`#B("@#G<4&0($%5;'
MLAP+@K<`-6#_A?^U7V80`%9P*\:<\1I?9O;A`$(VQV$!?Z:0!#&48`.*!"6P
M`-200LVJ!$.P`#X``FG07)<E)E*0X*WN=4ZP12AW!.DLCCJP!Q=Z.+ENV-QA
M!!N>V,Q[$-P(XOP,2V]0`E/`!%<Q`CFP`D/87!"0,XAW9$T0!4D@``LWHZ=]
M(Y?>X^N;6L8@9B?`!PCP1*8\MO0[:]2U+XE&!2MPZB]P#+,G%.(XH+X`4_L2
MYOFN=68NREB!!"\`!R"@`\Y$!2\0XZ"B(JBA`50@!%!P`(--:`AQ)Q!0`#`$
M`HN$2%T`@3Y'PQN?\3^'$;EAJ184-1@P`UFP`#E`K&X0``.?G[B7_T)+@`%/
M!`=G<`,S5``P+28X\`8Y+P%DT`*.@1!^L`"=$(%G8`0MX`0^_:=>C.>*@/2\
MWN%,_^'`#DL$P*:&H-E,DX$A5@)*X`4&@J`+NP<@H*8<4``+L`1FCP0F@/8_
MSE'#``@R/"LG>#-5'5PP#@Q),W5''B%_E)65)3)F5B0:1Y$00V\,(@XK*@TC
M.'Z6K$MP#PDZ)$,>&0!'(Q0!;C`U!PH06B](HC<.(F9O1ZR5&W]2GAHN,50O
M3,S8E@``&W4>'!HD*0$/Y>;G13K&#@GM#N_P\?+S$>\1]0D1*5<C=1`'8(AX
M4*)%`H\T01RD,/%BQ`0E??I8\D,Q`Q@E"_],!"AB9D$5,$N64/2#A(`*'0G.
M)"'3`L*1#<Z&R&``(T@`$TTP0+0DD=(++@XB?%C0QX^SB']&5O+S`V4%"A#\
M2)DJQ:@?2$PR$.`1E`$!+T0*O#@R`P>5"D'T?)`QT$N=I2,IOM`0(\"``B4*
M-`#V\H")""R"F"$@Y4_$PY0@O'AA`(2(#V\X.&G`0X>#!P9P0*OS%NZJ/D/$
MQ'@@Y@`D)1"J-#'QP,&-&`A>H*EZ.*Z?`S]6Q)H%(`.3(SAT)8`AY@4&"!X*
M,&G@H\(]$#]&^(FHU*H?7!1HI*#08$JV[[8V]`D1`@(:`F_2JU\O8T\*$1%N
MW(@O(HV-^_CSZ\?_#T.$"!CW1!#$#B<D`4%14CACF!\XX&'!#@DH-(<&49!1
M@A<]$-$;$CC@L$0!&KAG!PD('+!-!A"X5$<6&GP``PP"&%%`%DIX4,<,&7B!
MQ%DLN%%!$GL1T0(1M'"@Q`Q@+'"':V;(D,4$'B`7@A\09)!!#TH,P5@Z*52C
M!'`XN$3E$BT`<(`$%OAW@@8?-=&"`@!D\<8'7210@0\>*:#A##.,@(9L:(P`
MAQDKN""!)%9NT%`!!%C@``LV"-`!#AX\I(07''"`PQL_J($2"`8@T0(&"Z!I
M10`I_'``!F!@@$$W,R"!Q!(<>('`&2L,0``$3(A)$`)I+H("'%'@@,0$_R64
ML,"?PR1AQ@TPQ$#!!BTX,0.C&CF@`Q4-?.'!!MQ`(,,'\T6`0AXO:`&!GSB,
M,$(#!Y2`1@X"6.$"'`<H^!TS)V:0RA`E<*#%`0077#`:,M3@@P$^^&#"`"8\
M/,#$%%=L<<5[[#&Q"7OX<$45G3'S;@<HV)"`#=L9IR$8+#F!@0(O-)"$1E98
M8`0:)7R[@1\>?*-%$BZDH4\.."3KA0=$D.'%`GB8<5\:>[R1A1=#`C#%!)AZ
MT4`%-HA@@08C.+%$BE(QP80')7R1!1HJV)"&*6A,,$0&.X_$1)Q:_("%`S"`
MD$0!'(RZC1,C;('"(G?\0$`+/60PA0(%+-%$`?\X$$"H$!<L$,(&9M>1*0Y)
MQ."`&PJ90``:.*"QP`L$)#$'#RGL`"`#"`#@A`('$"!:&FF@8$0#5110@`(*
M5.%%`0>`;H$=AFIQ!!-(B/>E!C6<($(L9L#1@+%3`!"P%FAHX$,*=)SAPQL`
MK+&!%TZT>(,;00R@00D];`.`!VATP(`50=BK_0L*6$,/>L"!+!S@#:*YP0HX
M`:5]8>-;$)`5!)20J2P-X8(8O*#`4M&N-R0A"0C80@=&2,(2FO"$1DAA!^`@
M`0)\8178L-T+C*"&.BED+:A;`@;(``8D'*`!8K!``%9@`01H@0,3.,"Q9A`"
M#^!``P.HP"*\MH4%',#_<4D[P+(Z<(<@V,D'V\-!%8A`!"<P2@940`D,[O2&
M%RS!"S/("A/\@"PM:"`'%0B,#F)T.L#-0!(AZ,,(2F4&6`0A#3Q(P@)F4((L
M@4%K'3B#`X*P$!D<8`;LRU0!WE`#$JQ`"#]H``?JT`?QU*$$!TB"IQ+@!OA5
MP`P\4($*>&`&+L1N$98)0`X6X`$S^;`!5(B!9>Z0`PV@@6!(`,4"9)"#$[#!
M`G!H9"TRX(<0C.`(P?N!`*"E`Q1L@0`>(N`F?["'`("`!'!8P!"\@`$F5.$%
M)H@!#(9S!C'LQ18`F`$'"I"$$UAADB@0@PP:@`$GP#%_/%B2'<R`@"%P@`@.
M_V3&!"!!EA),@`,$:,`"-LI1CC;@H^F!@P7X$(.2FO2D*$VI2F,@A`](8!DQ
M7,,,T$##UD3@`2CPP0^2(`,92*`#5/A`75+P@2UDB@-^&H$D<"$#$]PA`@D(
MPDU18((K-``)E5)7%1:P![1$2P576(`"O```!2"`"BI(`2L3L`,!J*`&!)";
ME>:(OYD)X'KYV$%.8\.!GG'F""_HP`<>H(,@N,$&K^26%JJ`!`5X0!@_0,$#
M;A``$M0@"1H@``$D8`05./,$F2O!#&!2E",L0+`[8$<K$\""J.I`'>M0;2G,
MH`$M3&`#2!C"11M@@#MTP09WX($19/`&#<@``7,0:O\`&-`!P"E@"=RH@S4A
M0(0)O"`'#"@"0/>P4PD@X`<F.`$-W!J;9/TQ`QJ@PAWFXX8$=.$,)D@"$V`R
MD"QDP0@NT($-NB"`#\RA`PB`@Q%,<(8'=*$"B<3!%*80LHA28J*E1%;^)':Q
MC47L86H(0#U&U\H.>_C#'G9'.R(@@O[%``X0R(;5OH&&F<7@/PXX,!=0P``&
MU$4$.^#"'AJ@A"?AX`4X.()1,G``.=#`/_7107]H0`()X&`(.+!MGR0P@/?0
M@09`D(%N/4``*/`!!*FMAQ5$P(8QU,!8<Z428_B@AQLHN3\WX,,`T*"$$-1!
M"A%L`!".+(+"QN>3'4"#K`[_$`EEP>$#`1#!#5)P`EB2P`4"8`,(+&!5)4Q@
M"72[<^4^\(3_P.`&::C)B%^TX4F6HH@+F,`,J`0P(Q%@#B@H0AIV$`,7F,$,
M%CA##%8``A5L00,<"-X2NL&9".:S"@V@806&HX,[G($!)X@!&VC@@AK((+=&
MJI$"PB#/H,Q'!UT``1".T(>L5"%3IS5#!6X@`EX+X`Q<B`$(3F4^#4R`"$A8
MP`@<;`EPV>],+F"#'I!,</_P[N"+,.Q:V\'PACN\X:I=[6%!T`&8,H,BA@&7
M%MXP!S.,I@O^^70*!&"&'RP`"2$(5YB.``%C`8`)")`#%2BP!3S`@0(&,$$8
M"H"V_R/4P0]F`PXS<XZ`!?AA!A!8P`^@X`,CX$$&-A>#',(0A0FT<[X;L*8$
M+B`'"A@!#AW(`10,8$0O3(!*2,C`"_)@@`M\'0X_H((!Y""#$8P1$B.(WA06
ML`4#6.`.%0B`X&-P`A.DDXEUV,`48#(ETU[!``:@P`^V`/8.B-`(-1`#!>2N
M,0-T@`!#0/P?8'($*?3!'P38PAZF`0+!IR`&%B#["R#0Q`_1;0-1D8J0^Y"E
M!G3`!"C`0@Q24`$AF"$',EB`+280`D],:0D2,``5Q##"*XA![F&("A.42!:D
M(XP*%HAV"E)P!RY8@`IP((`6E."/(,.0WW\@PA0T5`<M$/\@J!;(O_[W3P(2
MW-H"6"`?]Q`4`5*`!GB`]\!P\!,M'9!BV%!-I60U1K(`&@`'8N`P&R,&"*!^
M?T1&&^`)GK`NVX![#?`&#7!$6K``&E4`&C(%%`$<$+`!/;`$*KA1$.`-1R`6
MRV);ZP(^#3![4[`$0@83,S`!BO%1)Y>";T``ES0%3"0%+5B"&B4PX/,")^<!
M\Z<A$:1XI/(&,K`%8I`#5)`#1B`!"W!$FU-*I"5=:)."&J4%6H`#OQ`22U`P
M5JB"\#(!JD9*H]<;$"`%=3`$:(`&;_!3<Y`#.4`!""`#!.!&3%`'O9$!B==R
M0L89I#0!53`$/^1=1B`&&IA\1[3_`94R`RS'#6!`/$=T;D?%6"LW5]W@!P%#
M@0C0`2ET!1U@20<P05#B+A@'?W]0)?/E.3.P41I0C,9XC!G5`.AQ`4(@<"OP
MC-`8C=(XC<]H!W:P`UU@!X7R4MG`,^7&(0=`"Y!8AXNQ.N$X`R$1$$0P)522
M(B_!#1Z0/,@A-QU2(U8#`*7E$@``!E,P`@"S`?BD>#W@!`-4'LCQ6!"`CB)!
M">"B(1GP(>%8([C@(4OP1Q$($L0#1WSR$!Y0!57P<O17B;VA5$?R"PJ0`134
M2%AW>G;61#.@!%G")T5H=4Z0B9C6*IB&'%Z0+#7R&?XV%;B`53V#`QQU`$SP
MDDH09&8C_XHA(`4=XG.20$I2D%L7-4!$%I%84P61P'QUD`$:`@!$,$!Z"(=:
M@"$]-`)B`A-$6`*00SPM\";5T@.N@D04!1.^^`>EMPK"6`6'L&!^^9>6`I-#
MT``]58P]=9B(F9B*"742@)AO4`#OQPI7(16I8$5+,$"N4E!.\)`/J0#SET^2
M<!TI0FRX)RM+`#D%L#I#$`*Q0FZ>0!&]T2%>0`8;@`&8!@!FYP&'4!;/Y07G
MJ"$C`2X9H`!(P'+%V42-=9N3N0'RER)+('\>Z07=DP%"%@F)!Q/7P1F8A`'S
M-P5#$!5#L`!F@R#5)`D;P`%1D0I5\I"R(BO$0SP'`$!"R'(>4/\;=2.:LI)/
MCT.'%^02+M$YI`B"6;<Y.W,`UP0!SZDAP>,)4@`]+B$%]F,VMC`%+Z,7&C`Y
M%=E^0E8V&Y!40T`\8+`&+/$FK'(V=@9T^L)O^N('+_!#/PB",.H)NBD)?-)R
M:!"'@YBC.KJC/*HZ5@23"T`F/<$,>):7%(&4,_`JVT!&NOF24.(/NW<=+Q$1
MP/%&7K`$>JA%!="35^%\*:<$C30!:P``<^-#$(`LR3(!"M`$38":&+`&:Q"<
M6>&?EZ*'1'"*HS*FI2><(U`C4P"3R9(IH6=I=P:AO[&5$\`A(8@Z"5D"X]$'
M+'<$3;0!4C`%50"'$>0JMD!&=PH2/=/_)XN!.M/A#%(Q%10QIS`*#3:*.CTC
M%:?WFO7Y<[W!<F4QB#W3,^:!.F`*="&1`521D!Q0`DXP!1[06!B0+!X`@Q31
MH*)(00)C+#,P!'5XD/>3>,\0F7=I&[T847&1%-KZK=WJK11!'=/Q'>%*"4CQ
M'44A$=O:KN_W&=L*%T/*$^(Z'8=1%&93%>-Z<4J!&*-'6MZ*#?[*K_W*KM\J
MF>WJ&?'Z@.=*"4JAL'"AKTOAL/;J&13[&0;KKM6QKYYQ>D71BQCWL>&ZL'=9
MLB9[LBB;LBJ[LBS;LB[[LC`;LS([LS1;LS9[LSB;LSJ[LSS;LS[[LT`;M$([
<M$1;M$9[M$B;$+1*N[1,V[1.^[10&[4G&P@`.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
